In the same year, i.e. 1967, Masato Tanabe et al. of SRI International published an article detailing on the reaction, and thus, some also refer to it as the Eschenmoser–Tanabe fragmentation.
TAS-108, also known as SR16234, is a drug discovered by Masato Tanabe and under development by SRI International and Taiho Pharmaceutical.
Masato Yoshino | Masato Tanaka | Masato Tanabe | Masato Onodera | Masato Wada | Masato Sakai | Tanabe, Wakayama | Tanabe | Masato Saito | Masato Nakamura | Masato "Max" Matsuura | Masato Kitano | Masato Kato | Masato Harada |